BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $910,029 | +46.3% | 34,510 | -4.5% | 0.00% | – |
| Q2 2023 | $621,866 | -0.3% | 36,155 | -3.9% | 0.00% | – |
| Q1 2023 | $623,740 | +34.7% | 37,620 | -38.0% | 0.00% | – |
| Q4 2022 | $463,000 | -24.0% | 60,717 | -0.9% | 0.00% | – |
| Q3 2022 | $609,000 | +250.0% | 61,247 | +219.1% | 0.00% | – |
| Q2 2022 | $174,000 | -74.2% | 19,195 | -52.5% | 0.00% | – |
| Q4 2021 | $674,000 | -65.6% | 40,372 | -3.4% | 0.00% | -100.0% |
| Q3 2021 | $1,960,000 | -16.5% | 41,812 | +8.5% | 0.00% | 0.0% |
| Q2 2021 | $2,348,000 | +8.3% | 38,519 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $2,169,000 | -28.4% | 35,211 | -17.3% | 0.00% | 0.0% |
| Q4 2020 | $3,030,000 | +82.6% | 42,602 | -3.7% | 0.00% | 0.0% |
| Q3 2020 | $1,659,000 | +8.7% | 44,239 | -5.5% | 0.00% | 0.0% |
| Q2 2020 | $1,526,000 | -10.0% | 46,802 | -20.0% | 0.00% | 0.0% |
| Q1 2020 | $1,696,000 | +66.9% | 58,492 | +101.9% | 0.00% | – |
| Q4 2019 | $1,016,000 | +71.9% | 28,973 | +5.2% | 0.00% | – |
| Q3 2019 | $591,000 | -12.7% | 27,544 | +9.7% | 0.00% | – |
| Q2 2019 | $677,000 | – | 25,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |